Analyze Diet

Topic:Disease Prevention

Disease prevention in horses encompasses strategies and practices aimed at minimizing the occurrence and spread of infectious and non-infectious diseases within equine populations. These practices include vaccination programs, biosecurity measures, and regular health monitoring. Vaccination helps to stimulate the horse's immune system to protect against specific pathogens, while biosecurity measures, such as quarantine and sanitation, reduce the risk of disease transmission. Regular health monitoring, including physical examinations and diagnostic testing, aids in early detection and management of potential health issues. This page compiles peer-reviewed research studies and scholarly articles that explore various methods and their effectiveness in preventing diseases in horses, as well as the development and implementation of prevention programs in different equine settings.
A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses.
Journal of virology    June 14, 2003   Volume 77, Issue 13 7244-7253 doi: 10.1128/jvi.77.13.7244-7253.2003
Li F, Craigo JK, Howe L, Steckbeck JD, Cook S, Issel C, Montelaro RC.Previous evaluations of inactivated whole-virus and envelope subunit vaccines to equine infectious anemia virus (EIAV) have revealed a broad spectrum of efficacy ranging from highly type-specific protection to severe enhancement of viral replication and disease in experimentally immunized equids. Among experimental animal lentivirus vaccines, immunizations with live attenuated viral strains have proven most effective, but the vaccine efficacy has been shown to be highly dependent on the nature and severity of the vaccine virus attenuation. We describe here for the first time the characterizati...
Mucosal co-administration of cholera toxin and influenza virus hemagglutinin-DNA in ponies generates a local IgA response.
Vaccine    June 12, 2003   Volume 21, Issue 21-22 3081-3092 doi: 10.1016/s0264-410x(03)00161-0
Soboll G, Nelson KM, Leuthner ES, Clark RJ, Drape R, Macklin MD, Swain WF, Olsen CW, Lunn DP.We have previously demonstrated that equine influenza virus hemagglutinin (HA) DNA vaccination protects ponies from challenge infection, and induces protective IgGa and IgGb responses. However, this approach does not induce a nasal IgA response. The objective of this study was to examine the value of cholera toxin (CT) administration as an adjuvant for intranasal HA DNA vaccination, and to measure protection 3 months after DNA vaccination. After an immunogenic dose of CT was determined, ponies were immunized on two occasions by intranasal administration of HA DNA and cholera toxin, or HA DNA a...
Optimising vaccination strategies in equine influenza.
Vaccine    June 12, 2003   Volume 21, Issue 21-22 2862-2870 doi: 10.1016/s0264-410x(03)00156-7
Park AW, Wood JL, Newton JR, Daly J, Mumford JA, Grenfell BT.A stochastic model of equine influenza (EI) is constructed to assess the risk of an outbreak in a Thoroughbred population at a typical flat race training yard. The model is parameterised using data from equine challenge experiments conducted by the Animal Health Trust (relating to the latent and infectious period of animals) and also published data on previous epidemics (to estimate the transmission rate for equine influenza). Using 89 ponies, an empirical relationship between pre-challenge antibody and the probability of becoming infectious is established using logistic regression. Changes in...
Testing for equine arteritis virus.
The Veterinary record    June 7, 2003   Volume 152, Issue 20 636 
Burr P, Snodgrass D.No abstract available
[A new product in the vaccination gap: the vector vaccine. Merial introduced an innovative influenza-tetanus vaccine for horses].
Tijdschrift voor diergeneeskunde    May 29, 2003   Volume 128, Issue 9 295-296 
Hulsen J.No abstract available
A practical approach to anthelmintic resistance.
Equine veterinary journal    May 21, 2003   Volume 35, Issue 3 218-219 doi: 10.2746/042516403776148174
Sangster N.No abstract available
Cutaneous leishmaniosis in three horses in Spain.
Equine veterinary journal    May 21, 2003   Volume 35, Issue 3 320-323 doi: 10.2746/042516403776148336
Solano-Gallego L, Fernández-Bellon H, Serra R, Gállego M, Ramis A, Fondevila D, Ferrer L.No abstract available
Guidelines for surveillance, prevention and control of West Nile virus.
Epidemiological bulletin    May 21, 2003   Volume 23, Issue 4 12-14 
No abstract available
Increases in cytokine and antimicrobial peptide gene expression in horses by immunomodulation with Propionibacterium acnes.
Veterinary therapeutics : research in applied veterinary medicine    May 21, 2003   Volume 4, Issue 1 5-11 
Davis EG, Rush BR, Blecha F.Immunomodulation with Propionibacterium acnes is used for prophylaxis of respiratory disease or in horses suffering from chronic pulmonary inflammation; however, the mechanism for this response is poorly understood. Semiquantitative reverse transcriptase-polymerase chain reaction assays were used to evaluate gene expression of interleukin (IL)-2, IL-10, interferon (IFN)-gamma, and NK-lysin in healthy horses treated with P. acnes. Findings in the study indicated that horses treated with a P. acnes-based immunomodulator exhibited increased IFN-gamma and NK-lysin gene expression in peripheral blo...
Molecular studies on Babesia, Theileria and Hepatozoon in southern Europe. Part I. Epizootiological aspects.
Veterinary parasitology    April 30, 2003   Volume 113, Issue 3-4 189-201 doi: 10.1016/s0304-4017(03)00078-5
Criado-Fornelio A, Martinez-Marcos A, Buling-Saraña A, Barba-Carretero JC.Molecular epizootiology of piroplasmids (Babesia spp., Theileria spp.) and Hepatozoon canis was studied in mammals from southern Europe (mainly from Spain, but also from Portugal and France). Partial amplification and sequencing of the 18s rRNA gene was used for molecular diagnosis. In some particular cases (B. ovis and B. bovis) the complete 18s rRNA gene was sequenced. Blood samples were taken from domestic animals showing clinical symptoms: 10 dogs, 10 horses, 10 cows, 9 sheep and 1 goat. In addition, DNA samples were isolated from blood of 12 healthy dogs and from spleen of 10 wild red fox...
Preliminary investigation of the probiotic potential of Lactobacillus rhamnosus strain GG in horses: fecal recovery following oral administration and safety.
The Canadian veterinary journal = La revue veterinaire canadienne    April 29, 2003   Volume 44, Issue 4 299-302 
Weese JS, Anderson ME, Lowe A, Monteith GJ.This study was designed to evaluate whether Lactobacillus rhamnosus strain GG (LGG), an extensively studied probiotic organism in humans, can colonize the intestines of adult horses and foals. Lactobacillus rhamnosus strain GG was administered to adult horses at doses of 1 x 10(9) CFU/50kg bodyweight (BW)/day (group 1, 7 horses), 1 x 10(10) colony forming units/ 50kg BW/day (group 2, 7 horses) and 5 x 10(10) colony forming units/50kg BW/day (group 3, 7 horses) for 5 d. Foals received 2 x 10(10) colony forming units/50kg BW/day (group 1, 7 foals) or 1 x 10(11) colony forming units/50kg BW/day (...
[The ‘Veterinary Information Point’, questions about export problems of horses].
Tijdschrift voor diergeneeskunde    April 18, 2003   Volume 128, Issue 7 219 
van Herten J.No abstract available
Efforts to pre-empt an equine influenza epidemic.
The Veterinary record    April 17, 2003   Volume 152, Issue 13 405-406 
Mumford J, Cardwell J, Daly J, Newton R.No abstract available
Evaluation of a commercially available hyperimmune plasma product for prevention of naturally acquired pneumonia caused by Rhodococcus equi in foals.
Journal of the American Veterinary Medical Association    April 12, 2003   Volume 220, Issue 1 59-63 doi: 10.2460/javma.2002.220.59
Giguère S, Gaskin JM, Miller C, Bowman JL.To determine efficacy of a commercially available hyperimmune plasma product for prevention of naturally acquired pneumonia caused by Rhodococcus equi in foals. Methods: Randomized clinical trial. Methods: 165 foals. Methods: Foals were randomly assigned to 1 of 2 groups (hyperimmune plasma or nontreated controls). Foals with failure of passive transfer (FPT) of immunity were treated with hyperimmune plasma and evaluated as a third group. Foals that received plasma were given 950 ml between 1 and 10 days of age and between 30 and 50 days of age. A tracheobronchial aspirate was obtained from fo...
Cutaneous and ocular habronemiasis in horses: 63 cases (1988-2002).
Journal of the American Veterinary Medical Association    April 11, 2003   Volume 222, Issue 7 978-982 doi: 10.2460/javma.2003.222.978
Pusterla N, Watson JL, Wilson WD, Affolter VK, Spier SJ.To describe clinical manifestations of cutaneous and ocular habronemiasis in horses and evaluate outcome of treatment. Methods: Retrospective study. Methods: 63 horses. Methods: The diagnosis was made on the basis of history, clinical signs, and identification of calcified concretions (sulfur granules) in lesions. Histologic examination of biopsy specimens was used to confirm the diagnosis. Case horses were compared with a control population of 12,720 horses examined during the same period. Results: Arabians, gray horses, and horses with diluted coat colors were overrepresented; Thoroughbreds ...
Verocytotoxin-producing Escherichia coli infection and private farm visits.
The Veterinary record    April 8, 2003   Volume 152, Issue 12 365-366 doi: 10.1136/vr.152.12.365
Willshaw GA, Evans J, Cheasty T, Cummins A, Pritchard GC.No abstract available
Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for Clostridia antiserum for serological potency testing of veterinary clostridial vaccines.
Developments in biologicals    April 8, 2003   Volume 111 171-180 
Lucken R, Daas A, Behr-Gross ME.The European Directorate for the Quality of Medicines (EDQM) has organised an international collaborative study, divided in two phases, aimed at producing and establishing a suitable reference serum for serological potency testing of clostridial vaccines for batch consistency demonstration. In phase 1 a series of pools produced from sera provided by each manufacturer and raised against the broadest range of antigens possible were blended to obtain TN titres which were representative of the range normally elicited by the vaccines under test. Detailed statistical analysis of the data was not pos...
Phenotypic mutants of the intracellular actinomycete Rhodococcus equi created by in vivo Himar1 transposon mutagenesis.
Journal of bacteriology    April 3, 2003   Volume 185, Issue 8 2644-2652 doi: 10.1128/JB.185.8.2644-2652.2003
Ashour J, Hondalus MK.Rhodococcus equi is a facultative intracellular opportunistic pathogen of immunocompromised people and a major cause of pneumonia in young horses. An effective live attenuated vaccine would be extremely useful in the prevention of R. equi disease in horses. Toward that end, we have developed an efficient transposon mutagenesis system that makes use of a Himar1 minitransposon delivered by a conditionally replicating plasmid for construction of R. equi mutants. We show that Himar1 transposition in R. equi is random and needs no apparent consensus sequence beyond the required TA dinucleotide. The...
An introductory survey of helminth control practices in south africa and anthelmintic resistance on Thoroughbred stud farms in the Western Cape Province.
Journal of the South African Veterinary Association    April 1, 2003   Volume 73, Issue 4 195-200 doi: 10.4102/jsava.v73i4.586
Matthee S, Dreyer FH, Hoffmann WA, van Niekerk FE.Fifty-one per cent of 110 questionnaires, designed for obtaining information on helminth control practices and management on Thoroughbred stud farms in South Africa, were completed by farmers during 2000. The number of horses per farm included in the questionnaire survey ranged from 15 to 410. Foals, yearlings and adult horses were treated with anthelmintics at a mean of 7.3 +/- 3.0, 6.6 +/- 2.7 and 5.3 +/- 2.3 times per year, respectively. An average of 3.4 different drugs were used annually, with ivermectin being used bymost farmers during 1997-2000. On 43% of farms the weights of horses wer...
Evaluation of a stochastic Markov-chain model for the development of forelimb injuries in Thoroughbred racehorses.
American journal of veterinary research    March 29, 2003   Volume 64, Issue 3 328-337 doi: 10.2460/ajvr.2003.64.328
Hill AE, Carpenter TE, Gardner IA, Stover SM.To evaluate a Markov-chain model for the development of forelimb injuries in Thoroughbreds and to use the model to determine effects of reducing sprint distance on incidence of metacarpal condylar fracture (CDY) and severe suspensory apparatus injury (SSAI). Methods: Weekly exercise and injury data for 122 Thoroughbreds during racing or training. Methods: Weekly data were used to construct a Markov-chain model with 5 states (uninjured [UNINJ], palpable suspensory apparatus injury [PSAII, SSAI, CDY, and lost to follow-up [LOST]). Transition probabilities between UNINJ and PSAI were estimated as...
Limited potential for mosquito transmission of genetically engineered, live-attenuated western equine encephalitis virus vaccine candidates.
The American journal of tropical medicine and hygiene    March 19, 2003   Volume 68, Issue 2 218-221 
Turell MJ, O'Guinn ML, Parker MD.Specific mutations associated with attenuation of Venezuelan equine encephalitis (VEE) virus in rodent models were identified during efforts to develop an improved VEE vaccine. Analogous mutations were produced in full-length cDNA clones of the Cba 87 strain of western equine encephalitis (WEE) virus by site-directed mutagenesis in an attempt to develop an improved WEE vaccine. Isogenic viral strains with these mutations were recovered after transfection of baby hamster kidney cells with infectious RNA. We evaluated two of these strains (WE2102 and WE2130) for their ability to replicate in and...
Strangles, bastard strangles, vives and glanders: archaeological relics in a genomic age.
Equine veterinary journal    March 18, 2003   Volume 35, Issue 2 118-120 doi: 10.2746/042516403776114252
Slater JD.No abstract available
Efficacy of an ivermectin-praziquantel combination in equids against bots and tapeworms.
The Veterinary record    March 8, 2003   Volume 152, Issue 6 178-179 doi: 10.1136/vr.152.6.178
Coles GC, Hillyer MH, Taylor FG, Villard I.No abstract available
International conference on equine grass sickness, Dubai, United Arab Emirates September 22-23, 2001.
Veterinary journal (London, England : 1997)    March 6, 2003   Volume 165, Issue 1 7-10 doi: 10.1016/s1090-0233(02)00131-4
Timoney PJ, Wernery U.No abstract available
Antifungal agents of use in animal health–practical applications.
Journal of veterinary pharmacology and therapeutics    February 27, 2003   Volume 26, Issue 1 31-53 doi: 10.1046/j.1365-2885.2003.00457.x
Rochette F, Engelen M, Vanden Bossche H.The purpose of this paper is to provide an overview of antifungal agents currently in use in veterinary medicine. The practical applications and the therapeutic regimens that have proved successful in the treatment and prevention of fungal infections in dogs and cats, cattle and sheep, horse, pig, poultry and other birds, rodents, rabbits and fur animals are summarized.
Evaluation of equine breeding farm management and preventative health practices as risk factors for development of Rhodococcus equi pneumonia in foals.
Journal of the American Veterinary Medical Association    February 25, 2003   Volume 222, Issue 4 476-485 doi: 10.2460/javma.2003.222.476
Chaffin MK, Cohen ND, Martens RJ.To determine whether foal management practices, environmental management, and preventative health practices are risk factors for development of Rhodococcus equi pneumonia in foals. Methods: Prospective matched case-control study. Methods: 2,764 foals on 64 equine breeding farms with 9,991 horses. Methods: During 1997, participating veterinarians completed paired data collection forms for comparison; 1 for an affected farm (containing > or = 1 foal with pneumonia caused by R equi) and 1 for a control farm. Information collected pertained to stabling facilities, environmental management, foal hu...
Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge.
Infection and immunity    February 22, 2003   Volume 71, Issue 3 1491-1496 doi: 10.1128/IAI.71.3.1491-1496.2003
Lee JS, Hadjipanayis AG, Welkos SL.Anthrax, a disease usually associated with herbivores, is caused by the bacterium Bacillus anthracis. The current vaccine licensed for human use requires a six-dose primary series and yearly boosters and causes reactogenicity in up to 30% of vaccine recipients. A minimally reactogenic vaccine requiring fewer inoculations is warranted. Venezuelan equine encephalitis (VEE) virus has been configured for use as a vaccine vector for a wide variety of immunogens. The VEE vaccine vector is composed of a self-replicating RNA (replicon) containing all of the VEE virus nonstructural genes and a multiple...
Occurrence of infectious upper respiratory tract disease and response to vaccination in horses on six sentinel premises in northern Colorado.
Equine veterinary journal    January 30, 2003   Volume 35, Issue 1 72-77 doi: 10.2746/042516403775467379
Mumford EL, Traub-Dargatz JL, Carman J, Callan RJ, Collins JK, Goltz KL, Romm SR, Tarr SF, Salman MD.Horses vaccinated against common agents of infectious upper respiratory disease (IURD) may not have detectable serum antibody and may not be protected from clinical disease. Objective: The objectives of this study were to 1) investigate the serological response of horses to vaccination against influenza virus (H3N8 and H7N7) and equine herpesviruses (EHV) in a field setting and 2) evaluate associations among vaccination status, serum antibody concentrations, and occurrences of IURD in monitored horses. Methods: In this study, horses on 6 Colorado premises were vaccinated parenterally against i...
Effects of high temperature and disinfectants on the viability of Sarcocystis neurona sporocysts.
The Journal of parasitology    January 23, 2003   Volume 88, Issue 6 1252-1254 doi: 10.1645/0022-3395(2002)088[1252:EOHTAD]2.0.CO;2
Dubey JP, Saville WJ, Sreekumar C, Shen SK, Lindsay OS, Pena HF, Vianna MC, Gennari SM, Reed SM.The effect of moist heat and several disinfectants on Sarcocystis neurona sporocysts was investigated. Sporocysts (4 million) were suspended in water and heated to 50, 55, 60, 65, and 70 C for various times and were then bioassayed in interferon gamma gene knockout (KO) mice. Sporocysts heated to 50 C for 60 min and 55 C for 5 min were infective to KO mice, whereas sporocysts heated to 55 C for 15 min and 60 C or more for 1 min were rendered noninfective to mice. Treatment with bleach (10, 20, and 100%), 2% chlorhexidine, 1% betadine, 5% o-benzyl-p-chlorophenol, 12.56% phenol, 6% benzyl ammoni...
Response of ELA-A1 horses immunized with lipopeptide containing an equine infectious anemia virus ELA-A1-restricted CTL epitope to virus challenge.
Vaccine    January 18, 2003   Volume 21, Issue 5-6 491-506 doi: 10.1016/s0264-410x(02)00474-7
Ridgely SL, Zhang B, McGuire TC.Lipopeptide containing an ELA-A1-restricted cytotoxic T lymphocyte (CTL) epitope from the envelope surface unit (SU) protein of the EIAV(WSU5) strain was used to immunize three horses having the ELA-A1 haplotype. Peptide-specific ELA-A1-restricted CTL were induced in all three horses, although these were present transiently in PBMC. These horses were further immunized with lipopeptide containing the corresponding CTL epitope from the EIAV(PV) strain. Then, the three immunized horses and three non-immunized horses were challenged by intravenous inoculation with 300 TCID(50) EIAV(PV). All horses...
1 68 69 70 71 72 119